Replimune Group Inc
NASDAQ:REPL

Watchlist Manager
Replimune Group Inc Logo
Replimune Group Inc
NASDAQ:REPL
Watchlist
Price: 8.2 USD 4.46% Market Closed
Market Cap: 631.5m USD
Have any thoughts about
Replimune Group Inc?
Write Note

Wall Street
Price Targets

REPL Price Targets Summary
Replimune Group Inc

Wall Street analysts forecast REPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REPL is 22 USD with a low forecast of 14.14 USD and a high forecast of 32.55 USD.

Lowest
Price Target
14.14 USD
72% Upside
Average
Price Target
22 USD
168% Upside
Highest
Price Target
32.55 USD
297% Upside
Replimune Group Inc Competitors:
Price Targets
300841
Chengdu Kanghua Biological Products Co Ltd
52% Upside
145020
Hugel Inc
23% Upside
688278
Xiamen Amoytop Biotech Co Ltd
38% Upside
6855
Ascentage Pharma Group International
19% Upside
VYGR
Voyager Therapeutics Inc
305% Upside
QURE
Uniqure NV
149% Upside
TECX
AVROBIO Inc
224% Upside
NBIX
Neurocrine Biosciences Inc
29% Upside

Revenue
Forecast

Revenue Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REPL's stock price target?
Price Target
22 USD

According to Wall Street analysts, the average 1-year price target for REPL is 22 USD with a low forecast of 14.14 USD and a high forecast of 32.55 USD.

Back to Top